Meiosis is a specialized cell division for gametogenesis that contributes to sexual reproduction by reducing the diploid chromosome number to the haploid 1 . During meiotic prophase I, homologous chromosomes undergo homolog pairing, synapsis, and reciprocal recombination, which are crucial for the chromosome segregation during metaphase I (refs.1-3). In most organisms studied to date, including mammals, repair of the programmed DNA double-stranded breaks (DSBs) introduced by SPO11 in leptotene initiates a genomewide search for homology [4] [5] [6] [7] . This search drives the homolog pairing and alignment, leading to assembly of a proteinaceous structure called the synaptonemal complex along the length of the paired homologs 8, 9 . The DSBs can be repaired either as a crossover or as a noncrossover 7, 8 , the former resulting in chiasmata that are essential for the correct alignment and segregation of homologous chromosomes during metaphase I (refs.10-12). Despite the importance of SPO11-mediated DSBs in mammalian meiotic synapsis, a significant level of homolog pairing at chromosomal ends was detected in mouse spermatocytes before programmed DSBs 13 . This is consistent with the observation that synapsis appears to initiate in subtelomeric regions in human spermatocytes 14 , suggesting a positive role of telomeres and subtelomeres in the initiation of meiotic homolog pairing.
a r t i c l e s human TERB1 in complex with the TRF-homology (TRFH) domain of human TRF1. Our structural and biochemical characterization reveals that TRF1 recognizes a unique IxLxP motif on TERB1 via the peptide-binding site in its TRFH domain. We generated knock-in mice with the TRF1-binding-deficient mutation in the Terb1 gene and studied the functional roles of the TERB1-TRF1 interaction in mouse meiosis. Strikingly, specific disruption of the TERB1-TRF1 interaction led to infertility only in male mice. We found that the Terb1 mutation caused an arrest in the zygotene-early pachytene stage of spermatogenesis and impaired X-Y chromosome pairing, resulting in massive spermatocyte apoptosis. The sex chromosomes possess short PARs 25 , and X-Y pairing is more challenging than autosomal pairing, owing to the deficiency of DNA interaction along the length of the chromosomes 26, 27 . Our studies suggest a mechanism of telomeres that helps surmount the unique challenges of X-Y pairing in meiosis.
RESULTS

Characterization of the interaction between TERB1 and TRF1
The TRFH domain of TRF1 is known to interact with TERB1, which functions together with TRF1 and SUN1 to regulate telomere-nuclear envelope attachment and telomere movement in meiosis 20, 21 . TRF1 TRFH was reported to directly interact with a C-terminal fragment of TERB1 (residues 522-662) 21 (Fig. 1a) . We confirmed this interaction using the yeast two-hybrid (Y2H) assay (Supplementary Fig. 1 ). To further map the TRF1-binding region in TERB1, we generated various TERB1 fragments of different lengths within TERB1 522-662 to evaluate their ability to interact with TRF1 TRFH by Y2H analysis. Our data revealed that a short fragment of TERB1 consisting of residues 642-656 was sufficient for binding to TRF1 (Supplementary Fig. 1 ). TERB1 642-656 binds TRF1 TRFH with an equilibrium dissociation constant (K d ) of 5.6 µM, measured by isothermal titration calorimetry (ITC) assay (Fig. 1b) . Hereafter, we will refer to TERB1 642-656 as TERB1 TBM (TRF1-binding motif) (Fig. 1a) . Our previous studies have demonstrated that TRF1 TRFH specifically recognizes a short peptide motif with a signature sequence FxLxP (x, any amino acid) on its interacting proteins, including TIN2 (ref. 28) . TERB1 TBM contains a modified sequence IxLxP that highly resembles the TRF1-binding motif of TIN2 (TIN2 TBM ) (Fig. 1c) , suggesting that TERB1 TBM might bind to TRF1 TRFH in the same manner as TIN2 TBM .
Crystal structure of the TERB1 TBM -TRF1 TRFH complex To reveal the structural basis for the specific recognition of TERB1 by TRF1, we crystallized TRF1 TRFH in complex with the TERB1 TBM peptide and determined the structure at a resolution of 2.1 Å by molecular replacement, using the previously determined structure of TRF1 TRFH as a search model 28 ( Table 1 , Fig. 1d and Supplementary Fig. 2a) . Except for three residues at the N and C termini, the TERB1 TBM peptide is well ordered, as evidenced by good electron density in the final atomic model (Supplementary Fig. 2a) .
The TRFH domain of TRF1 forms a homodimer, and each subunit contains ten meandering α-helices (Fig. 1d) . The TERB1 TBM peptide binds in an extended conformation across the concaved surface of each TRF1 TRFH subunit, burying ~700 Å 2 of total surface area at the intermolecular interface (Fig. 1d) . Each of the TERB1 TBM peptides contacts only one TRF1 TRFH subunit and does not interfere with the dimerization of TRF1 TRFH ( Fig. 1d and Supplementary  Fig. 2a a r t i c l e s adopts a sharp-turn conformation and binds to TRF1 TRFH through both van der Waals and electrostatic interactions (Fig. 1e) . The side chain of Leu647 TERB1 is inserted deeply into a hydrophobic pocket formed by a panel of residues of TRF1 TRFH with hydrophobic and aliphatic side chains (Leu86, Arg102, Ala105, Glu106, Ile109, Ile123, Cys126, Gln127, and Thr130) (Fig. 1e) . This van der Waals contact is buttressed by an elaborate network of hydrogen bonds between the backbone of TERB1 TBM surrounding Leu647 TERB1 and the side chains of TRF1 Glu106, Gln127, Thr130, and Arg131 (Fig. 1e) . In addition to Leu647 TERB1 , Pro649 TERB1 also contributes to complex formation via a stacking interaction between its pyrrolidine ring and the phenyl ring of Phe142 TRF1 (Fig. 1e) . The interaction between TRF1 TRFH and the C-terminal positively charged residues of TERB1 TBM ( 650 RRR 652 ) is dominated by electrostatic contacts ( Fig. 1f and Supplementary Fig. 2b ). This segment of TERB1 TBM adopts a short β-strand conformation that runs antiparallel to the one formed by the conserved residues ( 139 DAQ 141 ) of TRF1 (Fig. 1d,f) . This intermolecular β-sheet conformation is stabilized by electrostatic interactions; the guanidinium groups of Arg652 TERB1 and Arg650 TERB1 make four hydrogen-bonding interactions with Leu138, Asn144, and Glu146 of TRF1 (Fig. 1f) .
The structure of the TERB1 TBM -TRF1 TRFH complex reveals a striking similarity to that of the TIN2 TBM -TRF1 TRFH complex ( Supplementary Fig. 3a-c) . First, the central L-X-P motifs in both TRFH-binding motifs are identical in overall conformation, and the two key hydrophobic residues Leu647 and Pro649 of TERB1 interact with TRF1 in exactly the same way as their counterparts in TIN2 TBM do ( Supplementary Fig. 3a-c) . Second, in both complex structures, the side chain of one arginine residue (Arg652 in TERB1 and Arg266 in TIN2) at the C terminus of both TBM motifs points to a concaved acidic surface on TRF1 TRFH (Supplementary Fig. 3a-c) , suggesting that these electrostatic contacts make important contributions to the interaction between TRF1 and its binding partners. The major difference between the two structures is at the N termini before the central L-X-P motifs of the TBM peptides: 644 KIL 646 of TERB1 folds back onto the aliphatic side chain of Arg650 TERB1 to form a closed configuration, whereas 257 HFN 259 of TIN2 adopts a rather extended conformation with the phenyl ring of Phe258 TIN2 sitting on a flat hydrophobic surface of TRF1 TRFH (Supplementary Fig. 3a-c) .
Mutational analysis of the TERB1-TRF1 interface
To test the validity of the TERB1-TRF1 interaction observed in the crystal structure, we mutated residues of the TERB1 TBM peptide that were predicted to be important for interacting with TRF1 and then examined binding. We first focused on two highly conserved hydrophobic residues in TERB1, Leu647 and Pro649, whose equivalents in other TRFH-binding proteins are critical for their respective interactions [28] [29] [30] . Consistent with the structural data, ITC analysis with purified TRF1 TRFH and TERB1 TBM peptides showed that mutations of these key interacting residues either completely abolished (TERB1 L647A ) or substantially impaired (TERB1 P649A ) the a r t i c l e s TERB1-TRF1 interaction ( Supplementary Fig. 4) . A previous study showed that TERB1 T648 can be phosphorylated by cyclin-dependent kinase and that this modification is not compatible with the interaction between TERB1 and TRF1 (ref. 22 ). Indeed, a TERB1 TBM peptide with a phosphorylated Thr648 or a phosphomimetic glutamate residue at the position of Thr648 completely disrupted the interaction between TERB1 TBM and TRF1 TRFH ( Supplementary  Fig. 4 ). This finding is consistent with the crystal structure in which the hydroxyl group of TERB1 T648 is surrounded by a negative electrostatic surface of TRF1, which would generate unfavorable electrostatic conflict with TERB1 if a phosphorylated threonine or a glutamate residue were at the position of TERB1 T648 ( Supplementary Fig. 2b ).
We then tested the interactions of mutant proteins transiently expressed in human embryonic kidney 293T cells, and the coimmunoprecipitation (co-IP) results were consistent with the in vitro ITC measurements (Fig. 2a) . We therefore conclude that the observed TERB1-TRF1 interface is specific and necessary for both in vitro and in vivo binding of TERB1 to TRF1. Next, we tested the relevance of the TERB1-TRF1 interaction to the telomeric localization of TERB1 in HeLa cells by transiently expressing Flag-tagged WT or mutant TERB1. Indirect immunofluorescence (IF) analysis revealed a nuclear punctate staining pattern for WT TERB1 that almost completely colocalized with TRF1 and telomeres (Fig. 2b) . In contrast, TERB1 mutants containing single or multiple point mutations that disrupt the TRF1-TERB1 interaction were distributed throughout the nucleoplasm with no obvious accumulation at telomeres (Fig. 2b) . This result confirms the structural information and indicates that the binding of TERB1 TBM to the TRFH domain of TRF1 is required for the telomeric localization of TERB1.
Disruption of the TERB1-TRF1 interaction results in decreased fertility in male mice
To address the functional significance of the TERB1-TRF1 interaction in mammalian meiosis, we generated knock-in mice with the TRF1-binding-deficient mutation 647 LTP 649 to 647 AEA 649 in the Terb1 gene using the CRISPR-Cas9 method 31 ( Supplementary Fig. 5a,b) . The heterozygous Terb1 LTP/AEA mice were healthy and fertile and were intercrossed to produce homozygous Terb1 AEA/AEA mice. Pups were born close to the expected Mendelian ratio, and homozygous Terb1 AEA/AEA mice exhibited similar body weight compared to their WT and heterozygous littermates (data not shown), suggesting that the Terb1 AEA/AEA mutation does not impair embryonic development. Quantitative PCR (qPCR) and western blotting with mouse testis revealed that the Terb1 AEA/AEA mutation did not alter the in vivo mRNA and protein expression level of TERB1 ( Supplementary  Fig. 5c,d ). Strikingly, although some Terb1 AEA/AEA males produced offspring, most were infertile. In sharp contrast, Terb1 AEA/AEA females were fully fertile with normal litter sizes, strongly suggesting that the 647 AEA 649 mutation of TERB1 only affects male fertility.
Six-week-old testes of Terb1 AEA/AEA male mice were hypoplastic and about 35% in size compared with those of WT and heterozygous mice (Fig. 3a) . Histopathological analysis showed that the seminiferous tubules were narrower and lacked postmeiotic cells (Fig. 3b) . Furthermore, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) analysis of testis sections showed numerous a r t i c l e s apoptotic signals in Terb1 AEA/AEA seminiferous tubules, indicating that spermatocytes were massively eliminated in Terb1 AEA/AEA testes ( Fig. 3c,d) . Consequently, there were no or very few mature sperms in either the caput or cauda epididymal lumen of Terb1 AEA/AEA testes (Fig. 3b) . In sharp contrast, both the size of ovaries and the number of primordial follicles were indistinguishable between Terb1 AEA/AEA and control females (Fig. 3e,f) , in accordance with the observation that Terb1 AEA/AEA females were fully fertile.
Disruption of the TERB1-TRF1 interaction causes progressive loss of advanced spermatogenic cells
To reveal the reason for the absence of spermatozoa in Terb1 AEA/AEA mice, we first analyzed meiotic progression using fluorescenceactivated cell sorting (FACS) analysis. We found that although mature haploid sperms were generated in WT and heterozygous mice, the spermatogenesis process in Terb1 AEA/AEA mice was disrupted at the tetraploid stage of primary spermatocytes (Fig. 4a,b) . We further examined the progression of meiotic prophase I by immunostaining the axial element component SYCP3 and the synaptonemal complex protein SYCP1 on spermatocyte spreads 32, 33 . In WT mice at 21 d postpartum, more than 60% of the spermatocytes that expressed SYCP3 reached the pachytene or later stages (Fig. 4c,d ). In contrast, in Terb1 AEA/AEA mice, most of the spermatocytes were arrested in the zygotene (~60%) or pachytene-like (~15%) stages, and very few spermatocytes reached the diplotene stage (Fig. 4c,d) . Consistent with the immunostaining analysis, the Hoechst 33342 staining profile of Terb1 AEA/AEA spermatocytes showed an arrest at the zygotene-early pachytene stage (Supplementary Fig. 6a-c) . Next, we used fluorescence in situ hybridization (FISH) analysis of testis sections to further investigate the meiotic defect of Terb1 AEA/AEA mice. There were very few spermatocytes exhibiting telomere bouquets in WT and heterozygous testis sections, consistent with the fact that telomere clustering in the bouquet configuration occurs transiently during the zygotene stage [34] [35] [36] (Fig. 4e,f) . In contrast, there was an ~4-fold increase of the frequency of nuclei with telomere bouquets in Terb1 AEA/AEA testis sections (Fig. 4e,f) . Collectively, these results suggest that spermatogenesis in Terb1 AEA/AEA mice is delayed or arrested predominantly at the zygotene-early pachytene stage. Given that TERB1 plays an important role in homologous pairing, synapsis, and recombination during meiosis 21 , we next examined a r t i c l e s whether Terb1 AEA/AEA spermatocytes exhibit defects in these processes. IF staining of SYCP3, SYCP1, and MLH1 showed that autosomal homologous pairing, synapsis, and MLH1 focus formation (a crossover marker) appeared normal in Terb1 AEA/AEA spermatocytes ( Fig. 4c and Supplementary Fig. 7a,b) . To analyze whether the repair of meiotic programmed DSBs was impaired in Terb1 AEA/AEA testes, we analyzed spermatocyte spreads using γ-H2AX as a marker of DSBs 37 . WT and Terb1 AEA/AEA spermatocytes exhibited a similar γ-H2AX staining pattern with γ-H2AX distributed throughout entire nuclei in leptotene and early zygotene, solely restricted to the sex body in midpachytene to late diplotene, and eliminated in diakinesis (Supplementary Fig. 7c ). Taken together, our data suggest that, although the spermatogenesis is delayed in the zygotene-early pachytene stage, autosomal homologous crossing over, pairing, and synapsis are largely not affected in Terb1 AEA/AEA mice.
Disruption of the TERB1-TRF1 interaction impairs telomeric localization of TERB1 and SUN1
We demonstrated that point mutations of any residue in 647 LTP 649 of TERB1 disrupted the interaction between TERB1 and TRF1 when both proteins were tagged and coexpressed in HeLa cells ( Fig. 2a and Supplementary Fig. 4 ). We next examined the effect of the 647 AEA 649 mutation of TERB1 in the interaction between endogenous TERB1 and TRF1 in Terb1 AEA/AEA spermatocytes. Co-IP experiments showed that the 647 AEA 649 mutation greatly weakened the interaction (Supplementary Fig. 8a ). This result confirmed that the TBM motif of TERB1 is essential for TERB1-TRF1 interaction in spermatocytes.
We then investigated whether this mutation causes any defect in telomere localization of TERB1 in Terb1 AEA/AEA spermatocytes. IF analysis of WT spermatocyte spreads showed discrete TERB1 foci completely colocalized with telomeres (Fig. 5a) . In contrast, most telomeres exhibit substantially reduced TERB1 staining, and some of the telomeres completely lack TERB1 signal in Terb1 AEA/AEA spreads (Fig. 5a,b) . IF staining of SUN1 showed a similar defect in telomere localization in Terb1 AEA/AEA spreads ( Supplementary  Fig. 8b,c) , consistent with previous data that TERB1 recruits telomeres to INM through simultaneous interactions with both TRF1 and SUN1 in mouse spermatocytes 21 . Therefore, we conclude that disruption of the TERB1-TRF1 interaction impairs telomeric localization of TERB1 and SUN1 in spermatocytes.
Disruption of the TERB1-TRF1 interaction causes severe defect in sex-chromosome pairing
The telomere localization defect of the TERB1 647 AEA 649 mutant protein prompted us to investigate whether this mutation could cause structural abnormalities at telomeres such as splitting, bridging, and fusion, which are shown in Terb1 −/− spermatocytes 21 . Indeed, we observed on average two telomere splits or bridges and 1.5 telomere fusions between autosomal chromosomes per Terb1 AEA/AEA spread ( Fig. 5c-e) . These aberrant telomeres affected ~10% of autosomal chromosomes, which is >10-fold more frequent than in WT spermatocytes ( Fig. 5c-e) . Nevertheless, this phenotype is relatively mild and much less pronounced than the telomere aberrations in cells lacking TRF1 or TRF2 (refs. 38,39). 
a r t i c l e s
The most notable phenotype in Terb1 AEA/AEA spermatocytes was a very high incidence (~70%) of unpaired sex chromosomes (X and Y chromosomes) (Fig. 5f) , similar to the frequency of unpaired sex chromosomes observed in Spo11β-only spermatocytes 27 . In sharp contrast, no asynapsed autosomal chromosomes were found in Terb1 AEA/AEA spermatocytes (Fig. 5d,g ). In addition, Terb1 AEA/AEA spermatocyte spreads also showed telomere fusions between sex and autosomal chromosomes with a frequency much higher than that of fusions between autosomal telomeres (Fig. 5g) . Taken together, these data reveal that, although the 647 AEA 649 mutation of TERB1 causes telomere abnormalities in both autosomal and sex chromosomes, the defects of sex chromosomes are much more severe than those of autosomes.
DISCUSSION
In this report, we used both X-ray crystallography and mutational analyses to demonstrate that the TRFH domain of TRF1 specifically recognizes a short TBM sequence of TERB1, providing the first structural basis for how the telomere-INM connection is formed in meiosis. We have previously shown that the TRFH domain of TRF1 functions as a docking platform and recognizes a conserved TBM with a signature sequence of FxLxP in telomeric and telomereassociated proteins 28 . Notably, our data reveal that TERB1 TBM contains a modified TBM sequence, IxLxP, and that this motif of TERB1 and proteins that contain TBM sequences, including TIN2, all bind to the same molecular-recognition surface of the TRF1 TRFH domain in a manner that could be mutually exclusive ( Supplementary  Fig. 3a-c) . It is well established that TIN2 occupies a central position in the shelterin complex and simultaneously interacts with TRF1, TRF2, and TPP1, bridging three major DNA-binding modules in a highly organized manner [40] [41] [42] . The mutually exclusive TRF1 association between TERB1 and TIN2 suggests that there exist two separate TRF1-containing complexes in meiosis: the shelterin complex for telomere capping and the complex containing TERB1, TERB2, and MAJIN for specific telomere functions in meiosis.
TERB1, TERB2, and MAJIN form a meiotic telomere regulatory complex that anchors telomeres at the INM with the LINC complex and meiotic cohesin complex 21, 22 . This meiotic-specific interaction network is dynamically regulated and crucial for chromosome movement and homologous pairing, synapsis, and recombination 21, 22 . Disruption of the TERB1-TRF1 interaction partially abolishes this interaction network and leads to telomere aberrance and spermatogenesis arrest or delay in Terb1 AEA/AEA mice (Figs. 4 and 5) . This telomere aberrance is relatively mild, and a substantial amount of Terb1 AEA/AEA spermatocytes reach the pachytene stage with successful homolog pairing, synapsis, and recombination (Fig. 4c,d and Supplementary Fig. 7a,b) . Unlike autosomes, most of the X and Y chromosomes are unpaired in Terb1 AEA/AEA pachytene spermatocytes (Fig. 5f) . X-Y pairing is intrinsically more challenging than autosomal pairing, because X and Y chromosomes have only a very short subtelomeric PAR (<1 Mb) and cannot mediate efficient multiple-DNA interactions along the entire length of the chromosomes. We propose that meiotic-specific telomere structure that is mediated by the TERB1-TRF1 interaction and immediately adjacent to the PAR may play an important role in promoting X-Y pairing. Disruption of the TERB1-TRF1 interaction results in unpaired X and Y chromosomes at pachytene, consequently triggering an apoptosis response and leading to male infertility. In contrast, homologous pairing and synapsis in females can take place along the nearly 170-Mb length of the X chromosome and is therefore unlikely to require special help from telomeres, so that the Terb1 AEA/AEA female mice are fully fertile. Because the TERB1-TRF1 interface is conserved in humans, we speculate that TRF1-binding-deficient variants of TERB1 may be a human X-Y nondisjunction-susceptibility trait. We propose that aside from the critical capping function, telomeres play a vital role in meiosis via assisting X-Y pairing.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS
Protein expression and purification. Human TRF1 TRFH (residues 65-267) and TERB1 TBM (residues 642-656) were cloned into modified pET28a vector with a SUMO protein fused at the N terminus after the 6 × His tag and expressed in E. coli BL2-CodonPlus (DE3) cells (Stratagene). After induction for 18 h with 0.1 mM IPTG at 18 °C, the cells were harvested by centrifugation and the pellets were resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 10% Glycerol, 1mM PMSF, 5 mM benzamidine, 1 µg/mL leupeptin and 1 µg/mL pepstatin). The cells were then lysed by sonication and the cell debris was removed by ultracentrifugation. The supernatant was mixed with Ni-NTA agarose beads (Qiagen) and rocked for 1 h at 4 °C before elution with 250 mM imidazole. Then Ulp1 protease was added to remove the His-SUMO tag. TRF1 TRFH protein was further purified by gel-filtration chromatography on HiLoad Superdex75 column (GE Healthcare) equilibrated with 25 mM Tris-HCl, pH 8.0, 150 mM NaCl and 5 mM DTT. The purified TRF1 TRFH protein was concentrated to 20 mg/mL and stored at −80 °C. The TERB1 TBM peptide was further purified by gel-filtration chromatography on HiLoad Superdex75 column (GE Healthcare) equilibrated with 100 mM ammonium bicarbonate. The purified TERB1 TBM was concentrated by Speed Vac system and then lyophilized. The lyophilization products were then resuspended in water at a concentration of 50 mg/mL and stored at −80 °C. WT and mutant TERB1 TBM peptides used for ITC measurements were expressed and purified similarly.
Crystallization, data collection, and structure determination. TRF1 TRFH and TERB1 TBM were mixed at a molar ratio of 1:3 and the mixture was used for crystallization. Crystals of the TRF1 TRFH -TERB1 TBM complex were grown using the sitting drop vapor diffusion method at 16 °C. The precipitant-well solution consisted of 10% 2-propanol, 0.1M Tris-HCl, pH 8.5. Crystals were gradually transferred into a harvesting solution containing 20% 2-propanol, 0.1M TrisHCl, pH 8.5, and 25% glycerol before being flash frozen in liquid nitrogen for storage. Data sets were collected under cryogenic conditions (100 K) at the Shanghai Synchrotron Radiation Facility (SSRF) beamlines BL18U1 and BL19U1 (wavelength 0.97853 Å) and were processed by HKL3000 (ref. 43 ). TRF1 TRFH -TERB1 TBM complex structure was solved by molecular replacement by using the previously published TRF1 TRFH -TIN2 TBM complex structure (PDB 3BQO) as a searching model. The model was then refined using Refmac 44 , together with manual building in Coot 45 . In the final Ramachandran plot, the favored and allowed residues are 96.8% and 100.0%, respectively. All of the crystal structural figures were generated using PyMOL 46 .
Isothermal titration calorimetry (ITC).
The equilibrium dissociation constants of the WT and mutant TERB1 TBM interactions with TRF1 TRFH were determined using a MicroCal iTC200 calorimeter (Malvern). The enthalpies of binding between TRF1 TRFH (50-100 µM) and TERB1 TBM (500-1,000 µM) were measured at 16 °C in 25 mM Tris-HCl, pH 8.0, 150 mM NaCl. Three independent experiments were performed for every interaction described here. ITC data were subsequently analyzed and fit using Origin 7 software (OriginLab) with blank injections of peptides into buffer subtracted from the experimental titrations before data analysis.
Yeast two-hybrid assay. The yeast two-hybrid assays were performed as described previously 47 . Briefly, the L40 strain was transformed with pBTM116 and PACT2 (Clontech) fusion plasmids, and colonies harboring the both plasmids were selected on -leucine -tryptophan plates. The β-galactosidase activities were measured with a liquid assay.
Animals. Mice were housed under controlled environmental conditions with free access to water and food. Experimental protocols were approved by the regional ethical committee of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. We made every effort to minimize and refine our experiments to avoid animal suffering.
Generation of Terb1 AEA/AEA mice. The Terb1 LTP/LTP to Terb1 AEA/AEA mutation mice were generated using the CRISPR-Cas9 and single strand oligos as a donor 31 . Briefly, a single guide RNA (sgRNA: ACAAAGTTGTCTTCTTCTAC) was cloned into a sgRNA vector using OriGene's gRNA Cloning Services (Rockville, Maryland) and was then used as a template to synthesize sgRNAs using the MEGAshortscript T7 Kit (Life Technologies). Cas9 mRNA was in vitro transcribed from plasmid MLM3613 (Addgene #42251) using the mMESSAGE mMACHINE T7 Ultra Kit (Life Technologies). For microinjection, Cas9 mRNA (100 ng/µL) was mixed with sgRNA (50 ng/µL) and 100 ng/µL donor oligos (AAC  TAC TTA AAT TAC TGT TTT AAG TAT ACT AAA TGT TTT TTA TAT TTT  TCA GAA ATT TTG GCG GAA GCA TGC AGA AGA AGA CAA CTT TGT  AAA GAA TCT ACT GCC TCT GAA GAA CTA AGT AAG TAT ATT) and then microinjected into the cytoplasm of fertilized eggs collected from B6CBAF1/J F1 hybrid mice (JAX). The injected zygotes were cultured overnight in M16 medium at 37 °C in 5% CO 2 . In next morning, the embryos that had reached two-cell stage of development were implanted into the oviducts of pseudo-pregnant foster mothers (Swiss Webster, Taconic Farm). The mice born to the foster mothers were genotyped by tail biopsy. Briefly, purified tail DNA samples were amplified by PCR using a pair of forward (TCT ACA GCC ACC AGG CAC) and reverse (AGG GAG GAA GAC GGT GTC) primers. The PCR bands were then sequenced using primers GTT CAC TAA GGA TTC CTA CTA G (forward orientation) and TCA TGA AAG CCA AGG GTT ATC (reverse orientation). Mice with overlapping sequencing peaks at the intended mutation sites were bred with C57BL/6 mice for passing the desired mutations through the germline.
Histological analysis. The testes and ovaries were dissected and fixed in 4% paraformaldehyde in PBS for 4-12 h at 4 °C. Dehydration of tissues was done by passage through graded ethanol, and then tissues were cleared twice in xylene and embedded in paraffin. Tissue sections (5 µm) were prepared with a Leica RM2235 rotary microtome. HE staining was performed according to the standard protocol (Beyotime, C0105). TUNEL assay was carried out with TUNEL ApoGreen Detection Kit (Biotool, B31112). SLGP033R) before infecting plain HeLa cells. 48 h after infection, 1µg/mL puromycin was added to establish the stable-expressing populations. After 5 d of selection, cells were ready for immunofluorescence staining.
Co-IP and western blot. cDNA fragments were constructed into pEGFP-N1 (Clontech) and transfected into 293T cells. After 36 h, cells were collected and lysed and sonicated in lysis buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10% Glycerol, 0.5% TritonX-100, 1 mM EDTA) supplemented with EDTA-free complete protease inhibitor (Roche), sonicated on ice, and centrifuged (13,000 r.p.m., 15 min, 4 °C). The resulting supernatants were then precleared and immunoprecipitated with anti-FLAG M2 Affinity Gel (Sigma) overnight at 4 °C with constant rotation. Precipitates were then washed with lysis buffer, resuspended in Laemmli buffer, boiled for 5 min and used immediately on SDS-PAGE for immunoblotting. To detect WT and mutant TERB1 proteins in spermatocytes, testis samples from mouse littermates were homogenize in PBS buffer. Cells were pelleted and then lysed and sonicated in lysis buffer. Lysates were centrifuged and supernatants were prepared for SDS-PAGE. To detect the interaction between endogenous TERB1 and TRF1 in spermatocytes, mouse testis cell lysates were immunoprecipitated with anti-TERB1, and immunoprecipitated samples were subjected to western blot analysis. After SDS-PAGE, proteins were blotted onto PVDF membranes (Millipore). The blots were incubated in blocking buffer (5% fat-free milk in PBS buffer supplemented with 0.05% TWEEN-20) for 1 h at RT and were incubated in primary antibodies overnight at 4 °C. Blots were then washed and incubated in the alkaline-phosphatase-labeled or HRP-labeled secondary antibody for 1 h at RT. After being washed, blots were developed with BCIP/NBT substrate kit (Invitrogen, 002209) or ECL Prime western Blotting System (GE Healthcare, RPN2232).
Hoechst 33342 and PI staining for flow cytometry. Testes tissues were prepared for FACS based on previous studies 48, 49 with minor modifications. Briefly, decapsulated testes were incubated in DMEM medium supplemented with 1 mg/ml Collagenase type IV (Sigma) and 10 µg/mL DNase I (Roche) in 50-ml tubes at 33 °C for 20 min and shaken vigorously by hand. 1 mg/mL trypsin (Gibco) was then added to the tissue incubation medium and samples were incubated at 33 °C for another 20 min, with the tube being inverted several times every 5 min at 33 °C. The dissociated testis samples were pipetted with a plastic disposable Pasteur pipet ten times, and 10% FBS was added to inactivate trypsin. For Hoechst 33342 staining, samples were incubated with 100 µg/mL Hoechst 33342 and 10 µg/ml DNase I at 33 °C for 1 h and then passed through 40-µm cell strainers (BD Falcon). 10 µg/mL PI was added before FACS processing performed using a BD Influx cell sorter. For PI staining of fixed whole cells, dissociated testis samples were centrifuged (2,000 r.p.m., 15 min, 4 °C) and cell pellets were resuspended in 100 µL PBS and then 900 µL 75% ethanol was added. Cells were fixed overnight at 4 °C and washed once with PBS. Cells were then resuspended in PI staining solution (PBS supplemented with 0.1% TritonX-100, 200 µg/mL DNase-free RNase and 20 µg/mL PI) and incubated at 37 °C for 30min and then used for FACS analysis with a BD FACSCalibur Flow Cytometer.
Spermatocytes chromosome spreading. Chromosome spreading samples were prepared based on a previous study 50 . Briefly, testes were dissected and placed in PBS. Seminiferous tubules were separated and placed in a hypotonic extraction buffer (30 mM Tris-HCl, pH 8.2, 50 mM sucrose, 17 mM sodium citrate, 5 mM EDTA, 0.5 mM DTT and protease inhibitor cocktail (Roche)) for 30-60 min. Tubules were then moved to 100 mM sucrose solution (pH 8.2) and spermatocytes were detached by pipetting. Drops of cell suspension were then place on the upper right corner of cover slips (Thermo, 12-545-84) that were soaked in a 1% paraformaldehyde solution (Sigma, P6148), pH 9.2, supplemented with 0.15% Triton X-100. Nuclei were dried overnight at RT and stored at −80 °C.
Immunofluorescence staining, telomere FISH, microscopy, and fluorescencesignal quantification. For immunofluorescence staining of cultured cells, cells were grown on cover slips (Thermo, T_7011254584) and fixed in 4% paraformaldehyde, permeabilized with 0.15% Triton X-100, blocked with 3% BSA at RT for 1 h and incubated with primary antibodies. For immunofluorescence staining of spermatocyte spreads, spreads were washed with PBS buffer supplemented with 0.15% Triton X-100, blocked with 3% BSA at RT for 1 h and incubated with primary antibodies at 4 °C overnight. For immunofluorescence staining of paraffin-embedded tissue sections, sections on cover slips were dewaxed twice in fresh xylene for 15 min each, rehydrated in 100%, 95%, 75%, 50% ethanol and PBS for 10 min each. Sections were then incubated in retrieval solution (10 mM sodium citrate, 0.05% Tween 20, pH 6.0) and boiled for 1 min for antigen retrieval. After washed with PBS at RT for 10 min and blocked with 3% BSA at RT for 1 h, cover slips with sections were incubated with primary antibodies at 4 °C overnight. Cover slips with cells, sections or spreads were then washed and incubated with fluorescenceconjugated secondary antibodies at RT for 1 h. Cover slips were washed and ready for microscopy imaging. Combinatorial immunofluorescence staining and telomere FISH were carried out following the protocol described previously with minor modifications 51 . Briefly, after being incubated with secondary antibodies, cover slips were washed and refixed with 4% paraformaldehyde for 10 min, dehydrated in 70%, 85%, and 100% ethanol, air dried, and hybridized to PNA telomere probe (Panagene) in hybridization buffer (20 mM TrisHCl, pH 7.4, 70% formamide, 0.5% blocking reagent (Roche 11096176001)) using ThermoBrite system (Leica) (denatured at 85 °C for 5 min then kept at RT overnight for hybridization). Cover slips were washed once with hybridization buffer and then washed twice with 2× SSC buffer. Cover slips were then dehydrated in ethanol series and DNA was counterstained with DAPI. Microscopy imaging was then performed by LSM 710 (Zeiss) using 63× NA /1.40 oil. Fluorescence intensity quantification was carried out by using Imaris Image Analysis Software.
Data availability. The atomic coordinates and structure factors for the TRF1 TRFH -TERB1 TBM complex has been deposited to the Protein Data Bank (PDB) under the accession code PDB 5XUP. Source data for biochemical experiments that support the findings of this study are available from the corresponding author upon reasonable request. A Life Science Reporting Summary for this article is available. 
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Animal experiments were not randomized. Mouse littermates were allocated into experimental groups by the genotypes.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The investigators were blinded to the group allocation during experiments and outcome assessments.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
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